tirzepatide powder vial TIRZEPATIDE – Research Peptide |
Description
Review question Does treatment with once-weekly subcutaneous tirzepatide increase the risk of suicidal thoughts and dizziness in subjects with type 2 diabetes mellitus or obesity compared to placebo
Of the study group, 55.9% had type 2 diabetes
Tests may detect the hCG from the medication rather than from an actual pregnancy
Photos shared with written patient consent
9.Ma X, Lin Y, Lin L, et al
